UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?

Neurology, 2023-11, Vol.101 (20), p.873

2023

Volltextzugriff (PDF)

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

JAMA neurology, 2021-07, Vol.78 (7), p.787

2021

Volltextzugriff (PDF)

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort

JAMA neurology, 2021-07, Vol.78 (7), p.880

2021

Volltextzugriff (PDF)

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis

Journal of neuropathology and experimental neurology, 2017-05, Vol.76 (5), p.390-401

2017

Volltextzugriff (PDF)

Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset

Neurology, 2023-07, Vol.101 (1), p.e1

2023

Volltextzugriff (PDF)

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis

Journal of neurology, 2024-08, Vol.271 (8), p.5577-5589

2024

Volltextzugriff (PDF)

Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis

Neurology, 2023-02, Vol.100 (6), p.267

2023

Volltextzugriff (PDF)

Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial

Journal of neurology, 2024-04, Vol.271 (4), p.1649-1662

2024

Volltextzugriff (PDF)

Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis

Neurology, 2024-03, Vol.102 (6), p.e208032

2024

Volltextzugriff (PDF)

Adipokines in multiple sclerosis patients are related to clinical and radiological measures

Journal of neurology, 2023-04, Vol.270 (4), p.2018-2030

2023

Volltextzugriff (PDF)

The role of CD56bright NK cells in neurodegenerative disorders

Journal of neuroinflammation, 2024-02, Vol.21 (1), p.1-48, Article 48

2024

Volltextzugriff (PDF)

Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

Neurology, 2023-08, Vol.101 (5), p.e533

2023

Volltextzugriff (PDF)

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Multiple sclerosis, 2013-04, Vol.19 (5), p.593-600

2013

Volltextzugriff (PDF)

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Multiple sclerosis, 2020-10, Vol.26 (11), p.1309-1310

2020

Volltextzugriff (PDF)

Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2023-06, Vol.94 (6), p.487

2023

Volltextzugriff (PDF)

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

Multiple sclerosis, 2022-06, Vol.28 (7), p.1121-1125

2022

Volltextzugriff (PDF)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset

Multiple sclerosis, 2023-12, Vol.29 (14), p.1776-1785

2023

Volltextzugriff (PDF)

Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications

Neurology, 2012-09, Vol.79 (13), p.1369

2012

Volltextzugriff (PDF)

Information from ecological momentary assessments lead to over-medicalization: Commentary

Multiple sclerosis, 2024-07, Vol.30 (8), p.972-973

2024

Volltextzugriff (PDF)

Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis

Multiple sclerosis, 2024-02, Vol.30 (2), p.266-271

2024

Volltextzugriff (PDF)

Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes

Multiple sclerosis, 2024-01, Vol.30 (1), p.44-54

2024

Volltextzugriff (PDF)

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2023-06, Vol.94 (6), p.482

2023

Volltextzugriff (PDF)

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis

Multiple sclerosis, 2023-07, Vol.29 (8), p.1001-1011

2023

Volltextzugriff (PDF)

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11461

2022

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(78)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Neurosciences & Neurology
(65)
Clinical Neurology
(59)
Multiple Sclerosis
(53)
Humans
(49)
Neurosciences
(43)
Female
(16)
Magnetic Resonance Imaging
(16)
Multiple Sclerosis - Pathology
(15)
Male
(14)
Middle Aged
(14)
Multiple Sclerosis - Drug Therapy
(14)
Adult
(13)
Neurology
(12)
Regression Analysis
(11)
Multiple Sclerosis - Diagnostic Imaging
(10)
Original Research Papers
(10)
Brain - Diagnostic Imaging
(8)
Brain - Pathology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

How Far Are We in Translating the Multiple Sclerosis Prodromes in Clinical Practice?

Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis

Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis

Tumor Necrosis Factor α Blockers and the Risk of Multiple Sclerosis

Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial

Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis

Adipokines in multiple sclerosis patients are related to clinical and radiological measures

Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study

The role of CD56bright NK cells in neurodegenerative disorders

Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset

Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications

Information from ecological momentary assessments lead to over-medicalization: Commentary

Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis

Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

Suchergebnisse filtern